In vitro and murine models of DNM2-related centronuclear myopathy have begun to shed light on how DNM2 contributes to muscle defects [20], [21]; however, better models are needed to recapitulate disease characteristics and gain more meaningful insight into disease pathogenesis. This evidence concerns the gene DNM2 and autosomal dominant centronuclear myopathy.